Biotechnology Value Trading Fund Os LP
CIK 0001660683
Director
Filings
59
Latest May 18, 2026
Issuers covered
17
Showing
9 of 59
Page 2
Track record
71 of 111 open-market trades scored (64% price coverage) - 40 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 71 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 90 days | 68 | 71% | +33.6% | +10.4% | +171.4% | -51.5% |
| 180 days | 68 | 69% | +32.9% | +13.0% | +178.3% | -49.6% |
| 365 days | 65 | 58% | +46.0% | +3.4% | +284.7% | -54.3% |
Issuers
Companies where Biotechnology Value Trading Fund Os LP has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 13 | Jul 1, 2025 |
| OLMA | Olema Pharmaceuticals, Inc. | 7 | Jun 13, 2025 |
| RPTX | Repare Therapeutics Inc. | 7 | Jan 30, 2026 |
| XOMA | Xoma Corp | 6 | May 18, 2026 |
| MLTX | Moonlake Immunotherapeutics | 5 | Apr 2, 2026 |
| CGEM | Cullinan Oncology, Inc. | 4 | Jan 19, 2023 |
| CTIC | Cti Biopharma Corp | 3 | Jun 28, 2023 |
| ELDN | Eledon Pharmaceuticals, Inc. | 3 | Oct 31, 2024 |
| EPIX | Essa Pharma Inc. | 2 | Oct 14, 2025 |
| RAIN | Rain Oncology Inc. | 2 | Jan 29, 2024 |
| FDMT | 4d Molecular Therapeutics, Inc. | 1 | Nov 13, 2024 |
| ALLK | Allakos Inc. | 1 | May 19, 2025 |
| GLYC | Glycomimetics Inc | 1 | Jun 17, 2025 |
| PIRS | Pieris Pharmaceuticals, Inc. | 1 | Dec 17, 2024 |
| PNT | Point Biopharma Global Inc. | 1 | Dec 20, 2023 |
| GPCR | Structure Therapeutics Inc. | 1 | May 12, 2023 |
| THRD | Third Harmonic Bio, Inc. | 1 | Oct 31, 2024 |
All filings
59 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|